Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Xtant Medical Holdings (XTNT) over the last 17 years, with Q3 2025 value amounting to $10.6 million.

  • Xtant Medical Holdings' Cash & Current Investments rose 5016.93% to $10.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.6 million, marking a year-over-year increase of 5016.93%. This contributed to the annual value of $6.2 million for FY2024, which is 503.12% up from last year.
  • Per Xtant Medical Holdings' latest filing, its Cash & Current Investments stood at $10.6 million for Q3 2025, which was up 5016.93% from $7.0 million recorded in Q2 2025.
  • Over the past 5 years, Xtant Medical Holdings' Cash & Current Investments peaked at $20.5 million during Q2 2021, and registered a low of $4.4 million during Q2 2023.
  • For the 5-year period, Xtant Medical Holdings' Cash & Current Investments averaged around $11.5 million, with its median value being $8.7 million (2023).
  • As far as peak fluctuations go, Xtant Medical Holdings' Cash & Current Investments soared by 68543.36% in 2021, and later tumbled by 7359.77% in 2023.
  • Quarter analysis of 5 years shows Xtant Medical Holdings' Cash & Current Investments stood at $18.4 million in 2021, then increased by 11.53% to $20.5 million in 2022, then tumbled by 71.12% to $5.9 million in 2023, then increased by 5.03% to $6.2 million in 2024, then surged by 71.05% to $10.6 million in 2025.
  • Its Cash & Current Investments stands at $10.6 million for Q3 2025, versus $7.0 million for Q2 2025 and $5.4 million for Q1 2025.